Attagene, Inc. in the News

2008, March 13: Attagene was featured in an article, “ Accounting for all the Factors”, written by Matthew Mikulski of SciBx Weekly Feature: (Science-Business eXchange is a groundbreaking weekly publication)
Click here to for SciBx website. (Subscription required )
2008, February 24: Published article in Nature Methods: (Romanov et al., Nature Methods 5(3):253-60)
Click here to read the abstract.
Click here to read press release.
2008, February 24: Attagene has launched Factorial 30 TM; Evaluate 30 Transcription Factors in single experiment.
Click here to read PDF of product description. 2008, February 24: One Reporter for Many Transcription Factors, (TFs)
Click here to read the press release.
2007, April 11: Attagene has entered into a contract agreement with the U.S. EPA to perform bioactivity profiling of toxicants. (TOXCAST): The goal of this project is to improve predictive capacity of current compound evaluation approaches.
Click here to read EPA Press Release.
2004, July 15: Attagene has secured a U01 award from the NIH for $11.4 million over 5 years: This award is to perform genetic screens to identify components of innate immune responses by using proprietary reversible genetics technology.
2002 – 2004: Attagene has received two SBIR Phase 1 awards:
  • This award was provided for the development of novel biosensors for predictive toxicology.
  • This award was provided for development of new technology to profile signal transduction pathways in cancer.

Click the button below to get a free copy of Adobe PDF Reader.